Focused research across healthcare markets, technologies and evolving commercial landscapes.
Discuss a Healthcare ProjectExplore published healthcare market studies. Select a market name to open the full research document and switch between the RD and its table of contents.
The global PET radiopharmaceutical dose manufacturing and supply market was valued at USD 2.3 Billion in 2025. The market is expected to rise with a CAGR of 8.5% through 2035.
The global continuous glucose monitoring (CGM) market is estimated at USD 14.2 billion in 2025 and is projected to reach approximately USD 50.4 billion by 2035, representing a modeled 13.5% CAGR during 2026-2035.
Insulin Pump Market was valued at USD 6.6 billion in 2025 and is projected to reach USD 21.5 billion by 2035, expanding at a CAGR of 12.7% during 2026-2035.
Insulin Delivery Devices Market was valued at USD 20.26 billion in 2025 and is projected to reach USD 41.06 billion by 2035, expanding at a CAGR of 7.3% during 2026-2035.
Self-Monitoring Blood Glucose (SMBG) Market was valued at USD 21.6 billion in 2025 and is projected to reach USD 67.8 billion by 2035, expanding at a CAGR of 12.4% during 2026-2035.
Italy CGM Market was valued at USD 336.99 million in 2025 and is projected to reach USD 1.078 billion by 2035, expanding at a CAGR of 12.33% during 2026-2035
South Africa CGM Market was valued at USD 53.5 million* in 2025 and is projected to reach USD 97.7 million* by 2035, expanding at a CAGR of 5.6% during 2026–2035.
Japan CGM Market was valued at USD 419.29 million in 2025 and is projected to reach USD 1.281 billion by 2035, expanding at a CAGR of 11.81% during 2026-2035.
Germany CGM Market was valued at USD 1.011 billion in 2025 and is projected to reach USD 3.24 billion by 2035, expanding at a CAGR of 12.35% during 2026-2035.
Medical Imaging Market was valued at USD 46.0 billion in 2025 and is projected to reach USD 80.9 billion by 2035, expanding at a CAGR of 5.9% during 2026–2035.
China CGM Market was valued at USD 983.06 million in 2025 and is projected to reach USD 3.15 billion by 2035, expanding at a CAGR of 12.35% during 2026–2035.
U.S. CGM Market was valued at USD 7.80 billion in 2025 and is projected to reach USD 23.15 billion by 2035, expanding at a CAGR of 11.5% during 2026-2035.
Blood Glucose Monitoring Systems Market was valued at USD 16.8 billion in 2025 and is projected to reach USD 39.4 billion by 2035, expanding at a CAGR of 8.9% during 2026-2035.
NSAIDs Market was valued at USD 23.16 billion in 2025 and is projected to reach USD 37.73 billion by 2035, expanding at a CAGR of 5.0% during 2026–2035.
Market estimates, forecasts, segmentation and opportunity assessment.
Competitor mapping, benchmarking and strategic positioning.
Emerging technologies, adoption trends and market implications.
Customer needs, adoption drivers and evolving demand patterns.
Opportunity screening, entry considerations and route-to-market analysis.
Bespoke research built around a specific strategic question.